HEXO Corp is one of Canada’s leading cannabis producers through exceptional leadership, quality control and corporate vision. Explore our investor relations page for more information and to make inquiries about our TSX stock offering.
HEXO Corp. is pleased to announce that its common shares have been approved for listing on the NYSE American LLC (“NYSE American”) and will commence trading effective at the open of markets on January 23, 2019.
HEXO Corp. is pleased to announce the results of its annual general meeting of shareholders held on January 16, 2019. All items put forth at the meeting were approved, including the appointment of MNP LLP as auditor of the Company for the ensuing year, and the re-election of Nathalie Bourque, Vincent Chiara, Jason Ewart, Adam Miron, Dr. Michael Munzar and Sébastien St-Louis as directors of the Company, all with a majority of the votes cast, to hold office until the next annual meeting of shareholders or until their successors are elected or appointed.
HEXO Corp. is strengthening its commitment towards research and innovation by appointing Veronique Hamel as its Chief Innovation Officer. With global experience in new product development Ms. Hamel is well positioned to develop research strategy and oversee HEXO Corp’s research and innovation pipeline.
Want to keep in touch? We’ll send you our latest updates. You can unsubscribe at any time.